FATE - Fate Therapeutics Inc. (FATE) CEO Scott Wolchko on Q4 2021 Results - Earnings Call Transcript
Fate Therapeutics, Inc. (FATE) Q4 2021 Earnings Conference Call February 28, 2022 17:00 ET Company Participants Scott Wolchko - President and Chief Executive Officer Wayne Chu - Chief Medical Officer Ed Dulac - Chief Financial Officer Bob Valamehr - Chief Research and Development Officer Conference Call Participants Michael Yee - Jefferies Ashiq Mubarack - Citi Daina Graybosch - SVB Leerink Kelsey Goodwin - Guggenheim Nick Abbott - Wells Fargo Matt Biegler - Oppenheimer Robyn Karnauskas - Truist Securities David Dai - SMBC Peter Lawson - Barclays Presentation Operator Welcome to the Fate Therapeutics Fourth Quarter 2021 Financial Results Conference Call. [Operator Instructions] This call is being webcast live on the Investors section of Fate’s website at fatetherapeutics.com. As a reminder, today’s call is being recorded. I would now like to introduce Scott Wolchko, President and CEO of Fate Therapeutics. Scott Wolchko Thank you. Good afternoon and thanks everyone for joining
For further details see:
Fate Therapeutics, Inc. (FATE) CEO Scott Wolchko on Q4 2021 Results - Earnings Call Transcript